Table: Phoenixbio -2017/18 group results

PhoenixBio

15/05/2018 07:30

May 15 (Reuters)- 
          Phoenixbio Co., Ltd. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to        NEXT     
                Mar 31, 2018    Mar 31, 2017   Mar 31, 2019      YEAR       
                   LATEST         YEAR-AGO        COMPANY        COMPANY    
                   RESULTS         RESULTS       FORECAST      H1 FORECAST  
  Sales            902 mln          1.23           1.50          631 mln    
                 (-26.6 pct)     (+1.0 pct)     (+66.0 pct)    (+99.5 pct)  
  Operating     loss 268 mln       142 mln        124 mln      loss 67 mln  
                                 (-25.3 pct)                                
  Recurring     loss 267 mln       133 mln        122 mln      loss 69 mln  
                                 (-10.7 pct)                                
  Net
  Net           loss 270 mln       128 mln        104 mln      loss 75 mln  
                                 (+2.5 pct)                                 
  EPS          loss 93.36 yen     44.43 yen      35.87 yen   loss 26.10 yen 
  EPS Diluted                     44.17 yen                                 
  Ann Div            NIL             NIL            NIL                     
  -Q2 Div            NIL             NIL            NIL                     
  -Q4 Div            NIL             NIL            NIL                     
  
  NOTE - Phoenixbio Co., Ltd..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T